Radiopharmaceuticals in Nuclear Medicine Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Radiopharmaceuticals in Nuclear Medicine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Radiopharmaceuticals in Nuclear Medicine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Radiopharmaceuticals in Nuclear Medicine Overall Market Size
2.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size: 2021 VS 2027
2.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Radiopharmaceuticals in Nuclear Medicine Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Radiopharmaceuticals in Nuclear Medicine Players in Global Market
3.2 Top Global Radiopharmaceuticals in Nuclear Medicine Companies Ranked by Revenue
3.3 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Companies
3.4 Global Radiopharmaceuticals in Nuclear Medicine Sales by Companies
3.5 Global Radiopharmaceuticals in Nuclear Medicine Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Radiopharmaceuticals in Nuclear Medicine Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Radiopharmaceuticals in Nuclear Medicine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Radiopharmaceuticals in Nuclear Medicine Players in Global Market
3.8.1 List of Global Tier 1 Radiopharmaceuticals in Nuclear Medicine Companies
3.8.2 List of Global Tier 2 and Tier 3 Radiopharmaceuticals in Nuclear Medicine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Radiopharmaceuticals in Nuclear Medicine Market Size Markets, 2021 & 2027
4.1.2 Diagnostic Radiopharmaceuticals
4.1.3 Therapy Radiopharmaceuticals
4.1.4 Enriched Stable Isotopes
4.2 By Type - Global Radiopharmaceuticals in Nuclear Medicine Revenue & Forecasts
4.2.1 By Type - Global Radiopharmaceuticals in Nuclear Medicine Revenue, 2016-2021
4.2.2 By Type - Global Radiopharmaceuticals in Nuclear Medicine Revenue, 2022-2027
4.2.3 By Type - Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share, 2016-2027
4.3 By Type - Global Radiopharmaceuticals in Nuclear Medicine Sales & Forecasts
4.3.1 By Type - Global Radiopharmaceuticals in Nuclear Medicine Sales, 2016-2021
4.3.2 By Type - Global Radiopharmaceuticals in Nuclear Medicine Sales, 2022-2027
4.3.3 By Type - Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share, 2016-2027
4.4 By Type - Global Radiopharmaceuticals in Nuclear Medicine Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Radiopharmaceuticals in Nuclear Medicine Market Size, 2021 & 2027
5.1.2 Diagnostic Application
5.1.3 Therapeutic Application
5.1.4 Research
5.1.5 Pharmaceutical
5.1.6 Other
5.2 By Application - Global Radiopharmaceuticals in Nuclear Medicine Revenue & Forecasts
5.2.1 By Application - Global Radiopharmaceuticals in Nuclear Medicine Revenue, 2016-2021
5.2.2 By Application - Global Radiopharmaceuticals in Nuclear Medicine Revenue, 2022-2027
5.2.3 By Application - Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share, 2016-2027
5.3 By Application - Global Radiopharmaceuticals in Nuclear Medicine Sales & Forecasts
5.3.1 By Application - Global Radiopharmaceuticals in Nuclear Medicine Sales, 2016-2021
5.3.2 By Application - Global Radiopharmaceuticals in Nuclear Medicine Sales, 2022-2027
5.3.3 By Application - Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share, 2016-2027
5.4 By Application - Global Radiopharmaceuticals in Nuclear Medicine Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Radiopharmaceuticals in Nuclear Medicine Market Size, 2021 & 2027
6.2 By Region - Global Radiopharmaceuticals in Nuclear Medicine Revenue & Forecasts
6.2.1 By Region - Global Radiopharmaceuticals in Nuclear Medicine Revenue, 2016-2021
6.2.2 By Region - Global Radiopharmaceuticals in Nuclear Medicine Revenue, 2022-2027
6.2.3 By Region - Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share, 2016-2027
6.3 By Region - Global Radiopharmaceuticals in Nuclear Medicine Sales & Forecasts
6.3.1 By Region - Global Radiopharmaceuticals in Nuclear Medicine Sales, 2016-2021
6.3.2 By Region - Global Radiopharmaceuticals in Nuclear Medicine Sales, 2022-2027
6.3.3 By Region - Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Radiopharmaceuticals in Nuclear Medicine Revenue, 2016-2027
6.4.2 By Country - North America Radiopharmaceuticals in Nuclear Medicine Sales, 2016-2027
6.4.3 US Radiopharmaceuticals in Nuclear Medicine Market Size, 2016-2027
6.4.4 Canada Radiopharmaceuticals in Nuclear Medicine Market Size, 2016-2027
6.4.5 Mexico Radiopharmaceuticals in Nuclear Medicine Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Radiopharmaceuticals in Nuclear Medicine Revenue, 2016-2027
6.5.2 By Country - Europe Radiopharmaceuticals in Nuclear Medicine Sales, 2016-2027
6.5.3 Germany Radiopharmaceuticals in Nuclear Medicine Market Size, 2016-2027
6.5.4 France Radiopharmaceuticals in Nuclear Medicine Market Size, 2016-2027
6.5.5 U.K. Radiopharmaceuticals in Nuclear Medicine Market Size, 2016-2027
6.5.6 Italy Radiopharmaceuticals in Nuclear Medicine Market Size, 2016-2027
6.5.7 Russia Radiopharmaceuticals in Nuclear Medicine Market Size, 2016-2027
6.5.8 Nordic Countries Radiopharmaceuticals in Nuclear Medicine Market Size, 2016-2027
6.5.9 Benelux Radiopharmaceuticals in Nuclear Medicine Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Radiopharmaceuticals in Nuclear Medicine Revenue, 2016-2027
6.6.2 By Region - Asia Radiopharmaceuticals in Nuclear Medicine Sales, 2016-2027
6.6.3 China Radiopharmaceuticals in Nuclear Medicine Market Size, 2016-2027
6.6.4 Japan Radiopharmaceuticals in Nuclear Medicine Market Size, 2016-2027
6.6.5 South Korea Radiopharmaceuticals in Nuclear Medicine Market Size, 2016-2027
6.6.6 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Market Size, 2016-2027
6.6.7 India Radiopharmaceuticals in Nuclear Medicine Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Radiopharmaceuticals in Nuclear Medicine Revenue, 2016-2027
6.7.2 By Country - South America Radiopharmaceuticals in Nuclear Medicine Sales, 2016-2027
6.7.3 Brazil Radiopharmaceuticals in Nuclear Medicine Market Size, 2016-2027
6.7.4 Argentina Radiopharmaceuticals in Nuclear Medicine Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Sales, 2016-2027
6.8.3 Turkey Radiopharmaceuticals in Nuclear Medicine Market Size, 2016-2027
6.8.4 Israel Radiopharmaceuticals in Nuclear Medicine Market Size, 2016-2027
6.8.5 Saudi Arabia Radiopharmaceuticals in Nuclear Medicine Market Size, 2016-2027
6.8.6 UAE Radiopharmaceuticals in Nuclear Medicine Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Bracco Imaging S.P.A.
7.1.1 Bracco Imaging S.P.A. Corporate Summary
7.1.2 Bracco Imaging S.P.A. Business Overview
7.1.3 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.1.4 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2016-2021)
7.1.5 Bracco Imaging S.P.A. Key News
7.2 Cambridge Isotope Laboratories, Inc.
7.2.1 Cambridge Isotope Laboratories, Inc. Corporate Summary
7.2.2 Cambridge Isotope Laboratories, Inc. Business Overview
7.2.3 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.2.4 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2016-2021)
7.2.5 Cambridge Isotope Laboratories, Inc. Key News
7.3 Cardinal Health, Inc.
7.3.1 Cardinal Health, Inc. Corporate Summary
7.3.2 Cardinal Health, Inc. Business Overview
7.3.3 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.3.4 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2016-2021)
7.3.5 Cardinal Health, Inc. Key News
7.4 Covidien, Plc
7.4.1 Covidien, Plc Corporate Summary
7.4.2 Covidien, Plc Business Overview
7.4.3 Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.4.4 Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2016-2021)
7.4.5 Covidien, Plc Key News
7.5 Eczacibasi-Monrol
7.5.1 Eczacibasi-Monrol Corporate Summary
7.5.2 Eczacibasi-Monrol Business Overview
7.5.3 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.5.4 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2016-2021)
7.5.5 Eczacibasi-Monrol Key News
7.6 Fujifilm Holdings Corporation
7.6.1 Fujifilm Holdings Corporation Corporate Summary
7.6.2 Fujifilm Holdings Corporation Business Overview
7.6.3 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.6.4 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2016-2021)
7.6.5 Fujifilm Holdings Corporation Key News
7.7 GE Healthcare (Subsidiary Of General Electric Company)
7.7.1 GE Healthcare (Subsidiary Of General Electric Company) Corporate Summary
7.7.2 GE Healthcare (Subsidiary Of General Electric Company) Business Overview
7.7.3 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.4.4 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2016-2021)
7.7.5 GE Healthcare (Subsidiary Of General Electric Company) Key News
7.8 IBA Group
7.8.1 IBA Group Corporate Summary
7.8.2 IBA Group Business Overview
7.8.3 IBA Group Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.8.4 IBA Group Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2016-2021)
7.8.5 IBA Group Key News
7.9 Isotec, Inc. (Sigma-Aldrich)
7.9.1 Isotec, Inc. (Sigma-Aldrich) Corporate Summary
7.9.2 Isotec, Inc. (Sigma-Aldrich) Business Overview
7.9.3 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.9.4 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2016-2021)
7.9.5 Isotec, Inc. (Sigma-Aldrich) Key News
7.10 Lantheus Medical Imaging, Inc.
7.10.1 Lantheus Medical Imaging, Inc. Corporate Summary
7.10.2 Lantheus Medical Imaging, Inc. Business Overview
7.10.3 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.10.4 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2016-2021)
7.10.5 Lantheus Medical Imaging, Inc. Key News
7.11 Nordion, Inc.
7.11.1 Nordion, Inc. Corporate Summary
7.11.2 Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Business Overview
7.11.3 Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.11.4 Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2016-2021)
7.11.5 Nordion, Inc. Key News
7.12 Ntp Radioisotopes (Pty), Ltd.
7.12.1 Ntp Radioisotopes (Pty), Ltd. Corporate Summary
7.12.2 Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Business Overview
7.12.3 Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.12.4 Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2016-2021)
7.12.5 Ntp Radioisotopes (Pty), Ltd. Key News
7.13 Siemens Healthcare (Subsidiary Of Siemens AG)
7.13.1 Siemens Healthcare (Subsidiary Of Siemens AG) Corporate Summary
7.13.2 Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Business Overview
7.13.3 Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.13.4 Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2016-2021)
7.13.5 Siemens Healthcare (Subsidiary Of Siemens AG) Key News
7.14 Taiyo Nippon Sanso Corporation
7.14.1 Taiyo Nippon Sanso Corporation Corporate Summary
7.14.2 Taiyo Nippon Sanso Corporation Business Overview
7.14.3 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.14.4 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2016-2021)
7.14.5 Taiyo Nippon Sanso Corporation Key News
7.15 Urenco Limited
7.15.1 Urenco Limited Corporate Summary
7.15.2 Urenco Limited Business Overview
7.15.3 Urenco Limited Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.15.4 Urenco Limited Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2016-2021)
7.15.5 Urenco Limited Key News
7.16 Rotem Industries, Ltd., Inc.
7.16.1 Rotem Industries, Ltd., Inc. Corporate Summary
7.16.2 Rotem Industries, Ltd., Inc. Business Overview
7.16.3 Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.16.4 Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2016-2021)
7.16.5 Rotem Industries, Ltd., Inc. Key News
7.17 Australian Nuclear Association And Technology Organization (ANSTO)
7.17.1 Australian Nuclear Association And Technology Organization (ANSTO) Corporate Summary
7.17.2 Australian Nuclear Association And Technology Organization (ANSTO) Business Overview
7.17.3 Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.17.4 Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2016-2021)
7.17.5 Australian Nuclear Association And Technology Organization (ANSTO) Key News
7.18 Board of Radiation And Isotope Technology (BRIT)
7.18.1 Board of Radiation And Isotope Technology (BRIT) Corporate Summary
7.18.2 Board of Radiation And Isotope Technology (BRIT) Business Overview
7.18.3 Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.18.4 Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2016-2021)
7.18.5 Board of Radiation And Isotope Technology (BRIT) Key News
7.19 Institute of Atomic Energy Polatom Radioisotope Centre
7.19.1 Institute of Atomic Energy Polatom Radioisotope Centre Corporate Summary
7.19.2 Institute of Atomic Energy Polatom Radioisotope Centre Business Overview
7.19.3 Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.19.4 Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2016-2021)
7.19.5 Institute of Atomic Energy Polatom Radioisotope Centre Key News
7.20 Institute of Isotopes Co., Ltd.
7.20.1 Institute of Isotopes Co., Ltd. Corporate Summary
7.20.2 Institute of Isotopes Co., Ltd. Business Overview
7.20.3 Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.20.4 Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2016-2021)
7.20.5 Institute of Isotopes Co., Ltd. Key News
7.21 Institute Of Radioelement (IRE)
7.21.1 Institute Of Radioelement (IRE) Corporate Summary
7.21.2 Institute Of Radioelement (IRE) Business Overview
7.21.3 Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.21.4 Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2016-2021)
7.21.5 Institute Of Radioelement (IRE) Key News
8 Global Radiopharmaceuticals in Nuclear Medicine Production Capacity, Analysis
8.1 Global Radiopharmaceuticals in Nuclear Medicine Production Capacity, 2016-2027
8.2 Radiopharmaceuticals in Nuclear Medicine Production Capacity of Key Manufacturers in Global Market
8.3 Global Radiopharmaceuticals in Nuclear Medicine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Radiopharmaceuticals in Nuclear Medicine Supply Chain Analysis
10.1 Radiopharmaceuticals in Nuclear Medicine Industry Value Chain
10.2 Radiopharmaceuticals in Nuclear Medicine Upstream Market
10.3 Radiopharmaceuticals in Nuclear Medicine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Radiopharmaceuticals in Nuclear Medicine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer


List of Tables
Table 1. Key Players of Radiopharmaceuticals in Nuclear Medicine in Global Market
Table 2. Top Radiopharmaceuticals in Nuclear Medicine Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Radiopharmaceuticals in Nuclear Medicine Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Radiopharmaceuticals in Nuclear Medicine Revenue Share by Companies, 2016-2021
Table 5. Global Radiopharmaceuticals in Nuclear Medicine Sales by Companies, (K MT), 2016-2021
Table 6. Global Radiopharmaceuticals in Nuclear Medicine Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Radiopharmaceuticals in Nuclear Medicine Price (2016-2021) & (USD/MT)
Table 8. Global Manufacturers Radiopharmaceuticals in Nuclear Medicine Product Type
Table 9. List of Global Tier 1 Radiopharmaceuticals in Nuclear Medicine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Radiopharmaceuticals in Nuclear Medicine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

Bracco Imaging S.P.A.
Cambridge Isotope Laboratories, Inc.
Cardinal Health, Inc.
Covidien, Plc
Eczacibasi-Monrol
Fujifilm Holdings Corporation
GE Healthcare (Subsidiary Of General Electric Company)
IBA Group
Isotec, Inc. (Sigma-Aldrich)
Lantheus Medical Imaging, Inc.
Nordion, Inc.
Ntp Radioisotopes (Pty), Ltd.
Siemens Healthcare (Subsidiary Of Siemens AG)
Taiyo Nippon Sanso Corporation
Urenco Limited
Rotem Industries, Ltd., Inc.
Australian Nuclear Association And Technology Organization (ANSTO)
Board of Radiation And Isotope Technology (BRIT)
Institute of Atomic Energy Polatom Radioisotope Centre
Institute of Isotopes Co., Ltd.
Institute Of Radioelement (IRE)